Red blood cell density changes in infected vervet monkeys treated with experimental drugs.

<p>Monkeys were infected with <i>T. b. rhodesiense</i> KETRI 2537 and upon confirmation of onset of second stage HAT, treated with (<b>A</b>) DB829 or (<b>B</b>) DB868. DB829 was administered intramuscularly for either 5 consecutive days (28–32 days post-infection) or 5 alternate (*) days (28, 30, 32, 34 and 36 days post-infection). DB868 was administered orally for 10 consecutive days (28–37 days post-infection). Symbols represent means (<b>A</b>; n = 2) or means and standard error of the mean (<b>B</b>; n = 4).